Abematsu M, Kagawa T, Fukuda S, Inoue T, Takebayashi H, Komiya S, Taga T (2006) Basic fibroblast growth factor endows dorsal telencephalic neural progenitors with the ability to differentiate into
oligodendrocytes but not gamma-aminobutyric acidergic neurons. J Neurosci Res 83:731-743.
Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, Colombo MP, Versura P, D'Errico-Grigioni A, Ferri E, Baccarani M, Lemoli RM (2006) Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 24:454-461.
Arenas E (2002) Stem cells in the treatment of Parkinson's disease. Brain Res Bull 57:795-808.
Arenas E (2005) Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts. Ann N Y Acad Sci 1049:51-66.
Arnhold S, Klein H, Klinz FJ, Absenger Y, Schmidt A, Schinkothe T, Brixius K, Kozlowski J, Desai B, Bloch W, Addicks K (2006) Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur J Cell Biol 85:551-565.
Baetge EE (1993) Neural stem cells for CNS transplantation. Ann N Y Acad Sci 695:285-291.
Bai Y, Hu Q, Li X, Wang Y, Lin C, Shen L, Li L (2004) Telomerase immortalization of human neural progenitor cells. Neuroreport 15:245-249.
Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, Perrier AL, Bruses J, Rubio ME, Topf N, Tabar V, Harrison NL, Beal MF, Moore MA, Studer L (2003) Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 21:1200-1207.
Bartlett PF, Reid HH, Bailey KA, Bernard O (1988) Immortalization of mouse neural precursor cells by the c-myc oncogene. Proc Natl Acad Sci U S A 85:3255-3259.
Bauer M, Meyer M, Sautter J, Gasser T, Ueffing M, Widmer HR (2001) Liposome-mediated gene transfer to fetal human ventral mesencephalic explant cultures. Neurosci Lett 308:169-172.
Beal MF (1998) Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol 44:S110-114.
Beardsley T (2000) Gene therapy setback. Sci Am 282:36-37.
Beck KD, Knusel B, Hefti F (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52:855-866.
Benabid AL, Deuschl G, Lang AE, Lyons KE, Rezai AR (2006) Deep brain stimulation for Parkinson's disease.
Mov Disord 21 Suppl 14:S168-170.
Bernard O, Reid HH, Bartlett PF (1989) Role of the c-myc and the N-myc proto-oncogenes in the immortalization of neural precursors. J Neurosci Res 24:9-20.
Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-393.
Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson's disease. Bioessays 24:308-318.
Biewenga JE, Destree OH, Schrama LH (1997) Plasmid-mediated gene transfer in neurons using the biolistics technique. J Neurosci Methods 71:67-75.
Bjorklund A (2000) Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp 231:7-15;
discussion 16-20.
Bjorklund A (2005) Cell therapy for Parkinson's disease: problems and prospects. Novartis Found Symp 265:174-186; discussion 187, 204-211.
Bjorklund A, Rosenblad C, Winkler C, Kirik D (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 4:186-200.
Bjorklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R (2003) Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2:437-445.
Bjorklund H, Dahl D, Haglid K, Rosengren L, Olson L (1983) Astrocytic development in fetal parietal cortex grafted to cerebral and cerebellar cortex of immature rats. Brain Res 285:171-180.
Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99:2344-2349.
Black MA, Tremblay R, Mealing GA, Durkin JP, Whitfield JF, Morley P (1996) The desglycinyl metabolite of remacemide hydrochloride is neuroprotective in cultured rat cortical neurons. J Neurochem 66:989-995.
Blandini F, Braunewell KH, Manahan-Vaughan D, Orzi F, Sarti P (2004) Neurodegeneration and energy metabolism: from chemistry to clinics. Cell Death Differ 11:479-484.
Blottner D, Stapf C, Meisinger C, Grothe C (1997) Localization, differential expression and retrograde axonal transport suggest physiological role of FGF-2 in spinal autonomic neurons of the rat. Eur J Neurosci 9:368-377.
Bongarzone ER, Foster LM, Byravan S, Verity AN, Landry CF, Schonmann VV, Amur-Umarjee S, Campagnoni AT (1996) Conditionally Immortalized Neural Cell Lines: Potential Models for the Study of Neural Cell Function. Methods 10:489-500.
Bossy-Wetzel E, Schwarzenbacher R, Lipton SA (2004) Molecular pathways to neurodegeneration. Nat Med 10 Suppl:S2-9.
Bouvier MM, Mytilineou C (1995) Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J Neurosci 15:7141-7149.
Brigstock DR, Klagsbrun M, Sasse J, Farber PA, Iberg N (1990) Species-specific high molecular weight forms of basic fibroblast growth factor. Growth Factors 4:45-52.
Brundin P, Bjorklund A (1987) Survival, growth and function of dopaminergic neurons grafted to the brain. Prog Brain Res 71:293-308.
Brundin P, Bjorklund A (1998) Survival of expanded dopaminergic precursors is critical for clinical trials. Nat Neurosci 1:537.
Brundin P, Dunnett S, Bjorklund A, Nikkhah G (2001) Transplanted dopaminergic neurons: more or less? Nat Med 7:512-513.
Brundin P, Karlsson J, Emgard M, Schierle GS, Hansson O, Petersen A, Castilho RF (2000a) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant 9:179-195.
Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, Rehncrona S, Lindvall O (2000b) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123 ( Pt 7):1380-1390.
Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606.
Caday CG, Klagsbrun M, Fanning PJ, Mirzabegian A, Finklestein SP (1990) Fibroblast growth factor (FGF) levels in the developing rat brain. Brain Res Dev Brain Res 52:241-246.
Carvey PM, Punati A, Newman MB (2006) Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant 15:239-250.
Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol 171:98-108.
Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM (1998) Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci 11:36-46.
Cattaneo E, McKay R (1990) Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347:762-765.
Cepko C (1988) Immortalization of neural cells via oncogene transduction. Trends Neurosci 11:6-8.
Chen CA, Okayama H (1988) Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638.
Cho YH, Kim DS, Kim PG, Hwang YS, Cho MS, Moon SY, Kim DW, Chang JW (2006) Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model.
Biochem Biophys Res Commun 341:6-12.
Choi DW (2005) Neurodegeneration: cellular defences destroyed. Nature 433:696-698.
Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH (2006) Nurr1 in Parkinson's disease and related disorders. J Comp Neurol 494:495-514.
Chung S, Shin BS, Hwang M, Lardaro T, Kang UJ, Isacson O, Kim KS (2006) Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24:1583-1593.
Claus P, Bruns AF, Grothe C (2004a) Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem J 384:559-565.
Claus P, Werner S, Timmer M, Grothe C (2004b) Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci Lett 360:117-120.
Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, Kraft T, Grothe C (2003) Differential
intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem 278:479-485. Epub 2002 Oct 2022.
Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW, 2nd, Lightfoot P, German R, Howles PN, Kier A, O'Toole BA, et al. (1995) Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-1873.
Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, Scott EW (2004) Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363:1432-1437.
Correia AS, Anisimov SV, Li JY, Brundin P (2005) Stem cell-based therapy for Parkinson's disease. Ann Med 37:487-498.
Corso TD, Torres G, Goulah C, Roy I, Gambino AS, Nayda J, Buckley T, Stachowiak EK, Bergey EJ, Pudavar H, Dutta P, Bloom DC, Bowers WJ, Stachowiak MK (2005) Assessment of viral and non-viral gene transfer into adult rat brains using HSV-1, calcium phosphate and PEI-based methods. Folia Morphol (Warsz) 64:130-144.
Corti S, Locatelli F, Papadimitriou D, Strazzer S, Comi GP (2004) Somatic stem cell research for neural repair:
current evidence and emerging perspectives. J Cell Mol Med 8:329-337.
Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S (1994) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414.
Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.
Proc Natl Acad Sci U S A 95:14723-14728.
Date I, Yoshimoto Y, Imaoka T, Miyoshi Y, Gohda Y, Furuta T, Asari S, Ohmoto T (1993) Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging. Brain Res 621:150-154.
Davis BR, Brown DB, Prokopishyn NL, Yannariello-Brown J (2000) Micro-injection-mediated hematopoietic stem cell gene therapy. Curr Opin Mol Ther 2:412-419.
Dawson TM, Dawson VL (2002) Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat Neurosci 5 Suppl:1058-1061.
Demarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I (2006) Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor
rasagiline. Mov Disord.
Deng J, Petersen BE, Steindler DA, Jorgensen ML, Laywell ED (2006) Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 24:1054-1064.
Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, Tajima N, Yamada H, Sawada H, Ishikawa H, Mimura T, Kitada M, Suzuki Y, Ide C (2004) Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701-1710.
Dinsmore J, Ratliff J, Jacoby D, Wunderlich M, Lindberg C (1998) Embryonic stem cells as a model for studying regulation of cellular differentiation. Theriogenology 49:145-151.
Dityateva G, Hammond M, Thiel C, Ruonala MO, Delling M, Siebenkotten G, Nix M, Dityatev A (2003) Rapid and efficient electroporation-based gene transfer into primary dissociated neurons. J Neurosci Methods 130:65-73.
Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163-221.
Dono R (2003) Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 284:R867-881.
Drucker-Colin R, Verdugo-Diaz L (2004) Cell transplantation for Parkinson's disease: present status. Cell Mol Neurobiol 24:301-316.
Dunnett SB (1991) Towards a neural transplantation therapy for Parkinson's disease: experimental principles from animal studies. Acta Neurochir Suppl (Wien) 52:35-38.
Dunnett SB (1999) Striatal reconstruction by striatal grafts. J Neural Transm Suppl 55:115-129.
Dunnett SB, Bjorklund A (1997) Basic neural transplantation techniques. I. Dissociated cell suspension grafts of embryonic ventral mesencephalon in the adult rat brain. Brain Res Brain Res Protoc 1:91-99.
Dunnett SB, Bjorklund A (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399:A32-39.
Dunnett SB, Bjorklund A, Lindvall O (2001) Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci 2:365-369.
Dunnett SB, Kendall AL, Watts C, Torres EM (1997) Neuronal cell transplantation for Parkinson's and Huntington's diseases. Br Med Bull 53:757-776.
Engele J, Bohn MC (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 11:3070-3078.
Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR (2001) FGF induces a switch in death receptor pathways in neuronal cells. J Neurosci 21:4996-5006.
Farkas LM, Dunker N, Roussa E, Unsicker K, Krieglstein K (2003) Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J Neurosci 23:5178-5186.
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: A Highly Efficient, Lipid-Mediated DNA-Transfection Procedure. PNAS 84:7413-7417.
Ferrari G, Minozzi MC, Toffano G, Leon A, Skaper SD (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 133:140-147.
Finklestein SP, Apostolides PJ, Caday CG, Prosser J, Philips MF, Klagsbrun M (1988) Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res 460:253-259.
Florkiewicz RZ, Sommer A (1989) Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci U S A 86:3978-3981.
Florkiewicz RZ, Baird A, Gonzalez AM (1991) Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4:265-275.
Forman MS, Trojanowski JQ, Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055-1063.
Francouer AM, Assalian, A. (1996) MICROCAT: A novel cell proliferation and cytotoxicity assay based on WST-1. Biochemica 3:19-25.
Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719.
Freed WJ, Zhang P, Sanchez JF, Dillon-Carter O, Coggiano M, Errico SL, Lewis BD, Truckenmiller ME (2005) Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells.
Exp Neurol 191 Suppl 1:S45-59.
Frisa PS, Goodman MN, Smith GM, Silver J, Jacobberger JW (1994) Immortalization of immature and mature mouse astrocytes with SV40 T antigen. J Neurosci Res 39:47-56.
Fukuda H, Takahashi J (2005) Embryonic stem cells as a cell source for treating Parkinson's disease. Expert Opin Biol Ther 5:1273-1280.
Galli R, Gritti A, Bonfanti L, Vescovi AL (2003) Neural stem cells: an overview. Circ Res 92:598-608.
Gartner A, Collin L, Lalli G (2006) Nucleofection of primary neurons. Methods Enzymol 406:374-388.
Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research.
Acta Physiol Scand 177:437-447.
Georgievska B, Kirik D, Bjorklund A (2004) Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J Neurosci 24:6437-6445.
Giordano S, Sherman L, Morrison R (1991) Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the rat central nervous system. Ann N Y Acad Sci 638:420-423.
Gonzalez AM, Berry M, Maher PA, Logan A, Baird A (1995) A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res 701:201-226.
Gospodarowicz D (1989) Fibroblast growth factor. Crit Rev Oncog 1:1-26.
Gray J (2000) Neural transplantation in neurodegenerative disease: current status and new directions.
Introduction. Novartis Found Symp 231:1-6.
Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Korner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Muller-Hartmann H, Nix M, Siebenkotten G, Kraus G, Lun K (2004) New non-viral method for gene transfer into primary cells. Methods 33:151-163.
Grothe C, Unsicker K (1992) Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic, and lesion-related responses. J Neurosci Res 32:317-328.
Grothe C, Meisinger C (1997) The multifunctionality of FGF-2 in the adrenal medulla. Anat Embryol (Berl) 195:103-111.
Grothe C, Otto D, Unsicker K (1989) Basic fibroblast growth factor promotes in vitro survival and cholinergic development of rat septal neurons: comparison with the effects of nerve growth factor. Neuroscience 31:649-661.
Grothe C, Haastert K, Jungnickel J (2006) Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration-Lessons from in vivo studies in mice and rats. Brain Res Brain Res Rev 20:20.
Grothe C, Zachmann K, Unsicker K, Westermann R (1990) High molecular weight forms of basic fibroblast growth factor recognized by a new anti-bFGF antibody. FEBS Lett 260:35-38.
Grothe C, Wewetzer K, Lagrange A, Unsicker K (1991) Effects of basic fibroblast growth factor on survival and choline acetyltransferase development of spinal cord neurons. Brain Res Dev Brain Res 62:257-261.
Grothe C, Schulze A, Semkova I, Muller-Ostermeyer F, Rege A, Wewetzer K (2000) The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro. Neuroscience 100:73-86.
Grothe C, Timmer M, Scholz T, Winkler C, Nikkhah G, Claus P, Itoh N, Arenas E (2004) Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons. Neurobiol Dis 17:163-170.
Guan K, Chang H, Rolletschek A, Wobus AM (2001) Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 305:171-176.
Haastert K, Grosskreutz J, Jaeckel M, Laderer C, Bufler J, Grothe C, Claus P (2005) Rat embryonic
motoneurons in long-term co-culture with Schwann cells-a system to investigate motoneuron diseases on a cellular level in vitro. J Neurosci Methods 142:275-284.
Hagell P, Brundin P (2001) Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 60:741-752.
Hagell P, Piccini P, Bjorklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O (2002) Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 5:627-628.
Hamaue N, Minami M, Terado M, Hirafuji M, Endo T, Machida M, Hiroshige T, Ogata A, Tashiro K, Saito H, Parvez SH (2004) Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus. Neurotoxicology 25:205-213.
Helt CE, Hoernig GR, Albeck DS, Gerhardt GA, Ickes B, Reyland ME, Quissell DO, Stromberg I, Granholm AC (2001) Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail. Exp Neurol 170:258-269.
Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, Wallen A, Benoit G, Hengerer B, Olson L, Perlmann T (2003) Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp Cell Res 288:324-334.
Hirsch EC, Hoglinger G, Rousselet E, Breidert T, Parain K, Feger J, Ruberg M, Prigent A, Cohen-Salmon C, Launay JM (2003) Animal models of Parkinson's disease in rodents induced by toxins: an update. J Neural Transm Suppl:89-100.
Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18:925-964.
Hornykiewicz O (1970) The metabolism of brain dopamine in human parkinsonism. Riv Patol Nerv Ment 91:281-286.
Hornykiewicz O (1973) Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull 29:172-178.
Hornykiewicz O (1974) The mechanisms of action of L-dopa in Parkinson's disease. Life Sci 15:1249-1259.
Hornykiewicz O (2001) Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Adv Neurol 86:1-11.
Hynes M, Rosenthal A (2000) Embryonic stem cells go dopaminergic. Neuron 28:11-14.
Ikonomidou C, Turski L (1995) Excitotoxicity and neurodegenerative diseases. Curr Opin Neurol 8:487-497.
Itoh T, Satou T, Dote K, Hashimoto S, Ito H (2005) Effect of basic fibroblast growth factor on cultured rat neural stem cell in three-dimensional collagen gel. Neurol Res 27:429-432.
Jankovic J, Chen S, Le WD (2005) The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol 77:128-138.
Jaye M, Schlessinger J, Dionne CA (1992) Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135:185-199.
Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
Jungnickel J, Klutzny A, Guhr S, Meyer K, Grothe C (2005) Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants. Neuroscience 134:1343-1350.
Kanda S, Tamada Y, Yoshidome A, Hayashi I, Nishiyama T (2004) Over-expression of bHLH genes facilitate neural formation of mouse embryonic stem (ES) cells in vitro. Int J Dev Neurosci 22:149-156.
Kawabata I, Umeda T, Yamamoto K, Okabe S (2004) Electroporation-mediated gene transfer system applied to cultured CNS neurons. Neuroreport 15:971-975.
Kawasaki H, Suemori H, Mizuseki K, Watanabe K, Urano F, Ichinose H, Haruta M, Takahashi M, Yoshikawa K, Nishikawa S, Nakatsuji N, Sasai Y (2002) Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci U S A 99:1580-1585.
Keene CD, Ortiz-Gonzalez XR, Jiang Y, Largaespada DA, Verfaillie CM, Low WC (2003) Neural
differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 12:201-213.
Kilpatrick TJ, Bartlett PF (1995) Cloned multipotential precursors from the mouse cerebrum require FGF-2, whereas glial restricted precursors are stimulated with either FGF-2 or EGF. J Neurosci 15:3653-3661.
Kim BH, Kim JI, Choi EK, Carp RI, Kim YS (2005) A neuronal cell line that does not express either prion or doppel proteins. Neuroreport 16:425-429.
Kim DW (2004) Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease. Yonsei Med J 45 Suppl:23-27.
Kim JH, Panchision D, Kittappa R, McKay R (2003a) Generating CNS neurons from embryonic, fetal, and adult stem cells. Methods Enzymol 365:303-327.
Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56.
Kim JY, Koh HC, Lee JY, Chang MY, Kim YC, Chung HY, Son H, Lee YS, Studer L, McKay R, Lee SH (2003b) Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem 85:1443-1454.
Kim TE, Lee HS, Lee YB, Hong SH, Lee YS, Ichinose H, Kim SU, Lee MA (2003c) Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem Biophys Res Commun 305:1040-1048.
Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal
6-hydroxydopamine in the rat. Exp Neurol 152:259-277.
Kirik D, Georgievska B, Bjorklund A (2004) Localized striatal delivery of GDNF as a treatment for Parkinson
Kirik D, Georgievska B, Bjorklund A (2004) Localized striatal delivery of GDNF as a treatment for Parkinson